Zapatero J, Sanfeliu C, Bruseghini L
Arzneimittelforschung. 1981;31(10a):1816-9.
Acute toxicity studies of N-2-(p-chlorophenoxy)-isobutyryl-N'-morpholinomethylurea (plafibride, ITA 104) were carried out in mouse, rat, guinea pig and hamster by different administration routes. The effect of pretreatment with plafibride on acute toxicity was also studied for several days. Plafibride had low toxicity. Its LD50 p.o. was about 4000 mg/kg in rat, mouse and hamster. The LD50 i.p. was between 760 (673-859) mg/kg in NMRI mouse and 1050 (830-1328) mg/Kg in hamster. The LD50 i.v. was similar for rat and mouse (about 100 mg/kg). Pretreatment with plafibride did not alter acute toxicity, which implies the absence of accumulation of the compound which would have led to an increase in toxicity. Nor was there any appearance of enzymatic induction, in which case a decrease would be observed in the toxicity of the product.
通过不同给药途径对N-2-(对氯苯氧基)-异丁酰基-N'-吗啉甲基脲(普拉贝特,ITA 104)进行了小鼠、大鼠、豚鼠和仓鼠的急性毒性研究。还研究了普拉贝特预处理数天对急性毒性的影响。普拉贝特毒性较低。其经口半数致死量在大鼠、小鼠和仓鼠中约为4000毫克/千克。腹腔注射半数致死量在NMRI小鼠中为760(673 - 859)毫克/千克,在仓鼠中为1050(830 - 1328)毫克/千克。静脉注射半数致死量在大鼠和小鼠中相似(约100毫克/千克)。普拉贝特预处理未改变急性毒性,这意味着该化合物不存在会导致毒性增加的蓄积现象。也未出现酶诱导现象,否则会观察到该产品毒性降低。